BioHarvest Sciences Inc. (NASDAQ:BHST - Get Free Report)'s stock price rose 2.1% during mid-day trading on Tuesday . The company traded as high as $6.89 and last traded at $6.87. Approximately 2,920 shares were traded during trading, a decline of 70% from the average daily volume of 9,695 shares. The stock had previously closed at $6.73.
Analyst Ratings Changes
BHST has been the subject of a number of recent research reports. Craig Hallum initiated coverage on BioHarvest Sciences in a research note on Monday, May 5th. They set a "buy" rating and a $15.00 price objective for the company. HC Wainwright reiterated a "buy" rating and set a $14.00 price objective on shares of BioHarvest Sciences in a research note on Tuesday, April 8th.
Get Our Latest Research Report on BioHarvest Sciences
BioHarvest Sciences Trading Up 1.2%
The firm has a market capitalization of $113.30 million, a P/E ratio of -13.80 and a beta of 0.65. The company has a 50 day simple moving average of $6.67 and a two-hundred day simple moving average of $6.10.
BioHarvest Sciences (NASDAQ:BHST - Get Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. BioHarvest Sciences had a negative return on equity of 307.04% and a negative net margin of 31.30%. The business had revenue of $7.64 million during the quarter, compared to the consensus estimate of $8.93 million. On average, sell-side analysts expect that BioHarvest Sciences Inc. will post -0.8 EPS for the current fiscal year.
Institutional Trading of BioHarvest Sciences
Several hedge funds have recently modified their holdings of BHST. Magnus Financial Group LLC raised its holdings in shares of BioHarvest Sciences by 105.0% during the 1st quarter. Magnus Financial Group LLC now owns 71,733 shares of the company's stock worth $444,000 after acquiring an additional 36,733 shares in the last quarter. TD Waterhouse Canada Inc. purchased a new stake in shares of BioHarvest Sciences during the 4th quarter worth approximately $69,000. Finally, True North Advisors LLC raised its holdings in shares of BioHarvest Sciences by 7.6% during the 1st quarter. True North Advisors LLC now owns 44,391 shares of the company's stock worth $275,000 after acquiring an additional 3,120 shares in the last quarter.
About BioHarvest Sciences
(
Get Free Report)
BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.
Featured Stories
Before you consider BioHarvest Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioHarvest Sciences wasn't on the list.
While BioHarvest Sciences currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
